Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review
Stock Information for Elevate Credit Inc.
Loading
Please wait while we load your information from QuoteMedia.